Cargando…
Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy
Sepsis is a systemic response to infection with a high rate of mortality and complex pathophysiology involving inflammation, infection response, hemostasis, endothelium, and platelets. The purpose of this study was to develop an equation incorporating biomarker levels at intensive care unit (ICU) ad...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288806/ https://www.ncbi.nlm.nih.gov/pubmed/32129085 http://dx.doi.org/10.1177/1076029620902849 |
_version_ | 1783545341613703168 |
---|---|
author | Walborn, Amanda Rondina, Matthew Fareed, Jawed Hoppensteadt, Debra |
author_facet | Walborn, Amanda Rondina, Matthew Fareed, Jawed Hoppensteadt, Debra |
author_sort | Walborn, Amanda |
collection | PubMed |
description | Sepsis is a systemic response to infection with a high rate of mortality and complex pathophysiology involving inflammation, infection response, hemostasis, endothelium, and platelets. The purpose of this study was to develop an equation incorporating biomarker levels at intensive care unit (ICU) admission to predict mortality in patients with sepsis, based on the hypothesis that a combination of biomarkers representative of multiple physiological systems would provide improved predictive value. Plasma samples and clinical data were collected from 103 adult patients with sepsis at the time of ICU admission. Biomarker levels were measured using commercially available methods. A 28-day mortality was used as the primary end point. Stepwise linear regression modeling was performed to generate a predictive equation for mortality. Differences in biomarker levels between survivors were quantified using the Mann-Whitney test and the area under the receiver operating curve (AUC) was used to describe predictive ability. Significant differences (P < .05) were observed between survivors and nonsurvivors for plasminogen activator inhibitor 1 (AUC = 0.70), procalcitonin (AUC = 0.77), high mobility group box 1 (AUC = 0.67), interleukin (IL) 6 (AUC = 0.70), IL-8 (AUC = 0.70), protein C (AUC = 0.71), angiopoietin-2 (AUC = 0.76), endocan (AUC = 0.58), and platelet factor 4 (AUC = 0.70). A predictive equation for mortality was generated using stepwise linear regression modeling, which incorporated procalcitonin, vascular endothelial growth factor, the IL-6:IL-10 ratio, endocan, and platelet factor 4, and demonstrated a better predictive value for patient outcome than any individual biomarker (AUC = 0.87). The use of mathematical modeling resulted in the development of a predictive equation for sepsis-associated mortality with performance than any individual biomarker or clinical scoring system which incorporated biomarkers representative of multiple systems. |
format | Online Article Text |
id | pubmed-7288806 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-72888062020-06-22 Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy Walborn, Amanda Rondina, Matthew Fareed, Jawed Hoppensteadt, Debra Clin Appl Thromb Hemost Original Article Sepsis is a systemic response to infection with a high rate of mortality and complex pathophysiology involving inflammation, infection response, hemostasis, endothelium, and platelets. The purpose of this study was to develop an equation incorporating biomarker levels at intensive care unit (ICU) admission to predict mortality in patients with sepsis, based on the hypothesis that a combination of biomarkers representative of multiple physiological systems would provide improved predictive value. Plasma samples and clinical data were collected from 103 adult patients with sepsis at the time of ICU admission. Biomarker levels were measured using commercially available methods. A 28-day mortality was used as the primary end point. Stepwise linear regression modeling was performed to generate a predictive equation for mortality. Differences in biomarker levels between survivors were quantified using the Mann-Whitney test and the area under the receiver operating curve (AUC) was used to describe predictive ability. Significant differences (P < .05) were observed between survivors and nonsurvivors for plasminogen activator inhibitor 1 (AUC = 0.70), procalcitonin (AUC = 0.77), high mobility group box 1 (AUC = 0.67), interleukin (IL) 6 (AUC = 0.70), IL-8 (AUC = 0.70), protein C (AUC = 0.71), angiopoietin-2 (AUC = 0.76), endocan (AUC = 0.58), and platelet factor 4 (AUC = 0.70). A predictive equation for mortality was generated using stepwise linear regression modeling, which incorporated procalcitonin, vascular endothelial growth factor, the IL-6:IL-10 ratio, endocan, and platelet factor 4, and demonstrated a better predictive value for patient outcome than any individual biomarker (AUC = 0.87). The use of mathematical modeling resulted in the development of a predictive equation for sepsis-associated mortality with performance than any individual biomarker or clinical scoring system which incorporated biomarkers representative of multiple systems. SAGE Publications 2020-03-04 /pmc/articles/PMC7288806/ /pubmed/32129085 http://dx.doi.org/10.1177/1076029620902849 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Walborn, Amanda Rondina, Matthew Fareed, Jawed Hoppensteadt, Debra Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy |
title | Development of an Algorithm to Predict Mortality in Patients With
Sepsis and Coagulopathy |
title_full | Development of an Algorithm to Predict Mortality in Patients With
Sepsis and Coagulopathy |
title_fullStr | Development of an Algorithm to Predict Mortality in Patients With
Sepsis and Coagulopathy |
title_full_unstemmed | Development of an Algorithm to Predict Mortality in Patients With
Sepsis and Coagulopathy |
title_short | Development of an Algorithm to Predict Mortality in Patients With
Sepsis and Coagulopathy |
title_sort | development of an algorithm to predict mortality in patients with
sepsis and coagulopathy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288806/ https://www.ncbi.nlm.nih.gov/pubmed/32129085 http://dx.doi.org/10.1177/1076029620902849 |
work_keys_str_mv | AT walbornamanda developmentofanalgorithmtopredictmortalityinpatientswithsepsisandcoagulopathy AT rondinamatthew developmentofanalgorithmtopredictmortalityinpatientswithsepsisandcoagulopathy AT fareedjawed developmentofanalgorithmtopredictmortalityinpatientswithsepsisandcoagulopathy AT hoppensteadtdebra developmentofanalgorithmtopredictmortalityinpatientswithsepsisandcoagulopathy |